| Name | Title | Contact Details |
|---|
Intrinsic Therapuetics is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Southwest Technologies, Inc. offers healthcare providers information and resources in this section of our site. Journal Articles is a listing of professional articles which contain pertinent information regarding our products. Case Studies contains
Headquartered near Zurich, Switzerland, Phonak, a member of the Sonova Group, was born in 1947 from a passion and dedication to take on the most difficult hearing challenges. As the industry`s leading provider, we offer the broadest portfolio of life-changing hearing solutions. From pediatric to profound hearing loss, we remain committed to creating hearing solutions that change people`s lives to thrive socially and emotionally. We believe in changing lives and creating a world where `Life is on` for everyone.
Healthstar Laser Services Inc is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events. Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.